Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder
Authors:
- Christopher PittengerCPChristopher Pittenger
- Ben KelmendiBKBen Kelmendi
- Suzanne WasylinkSWSuzanne Wasylink
- Michael H. BlochMBMichael H. Bloch
- Vladimir CoricVCVladimir Coric
- 1 June 2008
- journal article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 28 (3) , 363-367
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- An Open-Label Trial of Riluzole, a Glutamate Antagonist, in Children with Treatment-Resistant Obsessive-Compulsive DisorderJournal of Child and Adolescent Psychopharmacology, 2007
- Beneficial Effects of the Glutamate-modulating Agent Riluzole on Disordered Eating and Pathological Skin-picking BehaviorsJournal of Clinical Psychopharmacology, 2006
- Memantine augmentation for refractory obsessive–compulsive disorderProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2006
- A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorderMolecular Psychiatry, 2006
- Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorderNeuroRX, 2006
- Memantine for Treatment-Resistant OCDAmerican Journal of Psychiatry, 2005
- Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label TrialBiological Psychiatry, 2005
- Obsessive–Compulsive DisorderNew England Journal of Medicine, 2004
- Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorderPsychopharmacology, 2003
- On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorderProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2001